Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Case Series .

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 10

Case series

• It is a group or cluster of case reports that may be


generated by a single clinician, group of clinicians, a
hospital, pharmaceutical company, or most importantly a
regulatory agency.

• Case series are collections of patients, all of whom have


a single exposure, whose clinical outcomes are then
evaluated and described.

• Case series can be collections of patients with a single


outcome, looking at their antecedent exposures
• E g : case series on thalidomide induced
phocomelia and fatal alcohol syndrome

• Occasionally, case series may produce a false alarm


when the relationship is strictly spurious.
• For e.g. antiemetic doxylamine /pyridoxine, where
original case series suggested it was a teratogen,
but this was not confirmed by analysis of all
available data.
Advantages
• After drug marketing, case series are most useful for
two related purposes.

Firstly they can be useful for quantifying the incidence


of an ADR . The so-called “Phase IV” post marketing
surveillance study of prazosin was conducted, to
quantitate the incidence of first-dose syncope from
prazosin.
• Secondly, they can be useful for being certain that any particular
adverse effect of concern does not occur when observed in a
population which is larger than that studied prior to drug
marketing.

The “Phase IV” postmarketing surveillance study was


conducted for cimetidine. Metiamide was an H-2 blocker, which
was withdrawn after marketing outside the US because it caused
agranulocytosis . Since cimetidine is chemically related to
metiamide there was a concern that cimetidine might also cause
Limitation
• In the absence of a control group, one cannot be certain which
features in the description of the patients are unique to the
exposure, or outcome.

• As an example, one might have a case series from a particular


hospital of 100 individuals with a certain disease, and note that all
were men over the age of 60. This might lead one to conclude that
this disease seems to be associated with being a man over the age
of 60.
Conclusion
• Case series is a pharmacoepidemiology study design.

• It analyse the data from various case reports in series.

• Case series are use full after marketing of drug to quantifying


the incidence of an adverse reaction and to develop certainty
between adverse reaction and exposure of the drug.

• Case series are not very useful in determining causation, but


provide clinical descriptions of a disease or of patients who
receive an exposure.
PARTS
1. TITLE
2. KEYWORDS
3. ABSTRACT
4. INTRODUCTION
5. INDIVIDUAL CASE PRESENTATION
6. DISCUSSION
7. CONCLUSION
8. REFERENCE

You might also like